Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00983606 · ClinicalTrials.gov registry record

An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants

A clinical trial of Healthy, sponsored by MedImmune.

Completed
Registry status
3,000
Enrollment target
20
Study locations

NCT00983606 is a study of Healthy that has completed, run by MedImmune. The registered enrollment target is 3,000 participants, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (365% higher). The trial reports 20 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00983606, a study of Healthy, has completed, sponsored by MedImmune.

COMPLETED
Registry status
3,000 participants
Enrollment target
20
Study locations

Study Summary

The primary objective is to assess the burden of respiratory disease in outpatient settings among 32 to 35 weeks' gestational age (wGA) infants in the USA who did not receive RSV prophylaxis during the infants' first RSV season.

Conditions Studied

Study Locations (20)

Alabama

  • Research Site - Birmingham
  • Research Site - Birmingham
  • Research Site - Dothan
  • Research Site - Greenville
  • Research Site - Mobile
  • Research Site - Prattville
  • Research Site - Scottsboro
  • Research Site - Selma
  • Research Site - Sylacauga
  • Research Site - Tuscaloosa

Arizona

  • Research Site - Chandler
  • Research Site - Mesa
  • Research Site - Phoenix
  • Research Site - Prescott
  • Research Site - Scottsdale

Arkansas

  • Research Site - Benton
  • Research Site - Bentonville
  • Research Site - Fort Smith
  • Research Site - Jonesboro
  • Research Site - Little Rock

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2009-09
Est. Completion 2011-07

Sponsor

MedImmune

210 total trials

What the Registry Record Tells You About NCT00983606

The ClinicalTrials.gov registry entry for NCT00983606 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (365% higher). The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00983606 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Arizona, Arkansas.

Frequently Asked Questions

What is clinical trial NCT00983606 about?

NCT00983606 is a clinical study titled "An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants". The primary objective is to assess the burden of respiratory disease in outpatient settings among 32 to 35 weeks' gestational age (wGA) infants in the USA who did not receive RSV prophylaxis during the infants' first RSV season.

What is the current status of trial NCT00983606?

This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2009-09. Estimated completion is 2011-07.

What conditions does trial NCT00983606 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT00983606?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00983606 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.